Castle Biosciences, Inc. Common Stock CSTL
$29.62
-3.04%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $44.33
- Implied Upside
- +49.7%
- Price Target Range
- $40.00 – $52.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-03 | BTIGMark Massaro |
Maintains | Buy | $40 → $44 |
| 2026-06-25 | Roth CapitalMax Masucci |
Initiates coverage on | Buy | $40 |
| 2026-05-13 | BTIGMark Massaro |
Maintains | Buy | $50 → $40 |
| 2026-05-07 | BairdCatherine Ramsey |
Maintains | Outperform | $44 → $43 |
| 2026-04-20 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $50 → $40 |
| 2026-02-27 | BairdCatherine Ramsey |
Maintains | Outperform | $41 → $44 |
| 2026-01-26 | GuggenheimSubbu Nambi |
Maintains | Buy | $43 → $47 |
| 2026-01-12 | Lake StreetThomas Flaten |
Maintains | Buy | $35 → $52 |
| 2026-01-05 | GuggenheimSubbu Nambi |
Maintains | Buy | $30 → $43 |
| 2025-12-22 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $37 → $50 |
| 2025-12-12 | BTIGMark Massaro |
Maintains | Buy | $38 → $50 |
| 2025-11-05 | BTIGMark Massaro |
Maintains | Buy | $32 → $38 |
| 2025-11-04 | BairdCatherine Ramsey |
Maintains | Outperform | $39 → $41 |
| 2025-09-09 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $37 |
| 2025-05-21 | ScotiabankSung Ji Nam |
Maintains | Sector outperform | $44 → $40 |
| 2025-05-06 | Lake StreetThomas Flaten |
Maintains | Buy | $40 → $35 |
| 2025-05-06 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $42 → $37 |
| 2025-02-28 | BairdCatherine Ramsey |
Maintains | Outperform | $36 → $37 |
| 2025-01-02 | Stephens & Co.Mason Carrico |
Reiterates | Overweight | $41 |
| 2024-11-06 | ScotiabankSung Ji Nam |
Maintains | Sector outperform | $37 → $44 |
| 2024-11-05 | Lake StreetThomas Flaten |
Maintains | Buy | $34 → $40 |
| 2024-11-05 | KeybancPaul Knight |
Maintains | Overweight | $28 → $36 |
| 2024-11-05 | BairdCatherine Ramsey |
Maintains | Outperform | $37 → $39 |
| 2024-10-29 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $35 → $42 |
| 2024-10-14 | BTIGSung Ji Nam |
Maintains | Buy | $35 → $40 |
| 2024-08-06 | Stephens & Co.Mason Carrico |
Reiterates | Overweight | $37 |
| 2024-08-06 | BairdCatherine Ramsey |
Maintains | Outperform | $34 → $37 |
| 2024-07-05 | BairdCatherine Ramsey |
Maintains | Outperform | $34 |
| 2024-05-03 | BairdCatherine Ramsey |
Maintains | Outperform | $33 → $34 |
| 2024-03-01 | KeybancPaul Knight |
Maintains | Overweight | $25 → $28 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $29.62
- Market Cap
- $960.17 million
- 52-Week Range
- $14.59 – $44.28
- Average Volume
- 428K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.